FYLDE_MEDICAL_LIMITED - Accounts


Company registration number 09492560 (England and Wales)
FYLDE MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
FYLDE MEDICAL LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
FYLDE MEDICAL LIMITED
BALANCE SHEET
AS AT
31 MARCH 2023
31 March 2023
- 1 -
2023
2022
Notes
£
£
£
£
Current assets
Debtors
5
197,580
205,355
Cash at bank and in hand
3,880
3,440
201,460
208,795
Creditors: amounts falling due within one year
6
(187,764)
(189,912)
Net current assets
13,696
18,883
Creditors: amounts falling due after more than one year
7
(35,275)
(39,690)
Net liabilities
(21,579)
(20,807)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(21,679)
(20,907)
Total equity
(21,579)
(20,807)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 24 November 2023
Dr  V  Kashyap
Director
Company registration number 09492560 (England and Wales)
FYLDE MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 2 -
1
Accounting policies
Company information

Fylde Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is 122 Fleetwood Road North, Thornton Cleveleys, Lancashire, FY5 4BL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

At the year end the company had net current liabilities of £21,579, which indicates that the company may not be a going concern. The company’s ongoing activities are dependent upon the continued financial support of the director, who has undertaken to provide such support for at least one year from the date on which these financial statements are approved. The director therefore considers it appropriate that the financial statements are prepared on a going concern basis.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

FYLDE MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 3 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
-
0
-
0
FYLDE MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 4 -
4
Fixed asset investments
2023
2022
£
£
5
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
65,639
73,895
Other debtors
131,941
131,460
197,580
205,355
6
Creditors: amounts falling due within one year
2023
2022
£
£
Bank loans
9,767
9,527
Trade creditors
157,534
157,713
Corporation tax
10,203
10,047
Other taxation and social security
10,260
12,625
187,764
189,912
7
Creditors: amounts falling due after more than one year
2023
2022
£
£
Bank loans and overdrafts
35,275
39,690
8
Directors' transactions

Included in other debtors is an amount owed from the director of £30,741.04 (2022: £30,915). This loan is provided unsecured and repayable on demand.

2023-03-312022-04-01false24 November 2023CCH SoftwareCCH Accounts Production 2023.300No description of principal activityDr V Kashyapfalse094925602022-04-012023-03-31094925602023-03-31094925602022-03-3109492560core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3109492560core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3109492560core:Non-currentFinancialInstrumentscore:AfterOneYear2023-03-3109492560core:Non-currentFinancialInstrumentscore:AfterOneYear2022-03-3109492560core:CurrentFinancialInstruments2023-03-3109492560core:CurrentFinancialInstruments2022-03-3109492560core:ShareCapital2023-03-3109492560core:ShareCapital2022-03-3109492560core:RetainedEarningsAccumulatedLosses2023-03-3109492560core:RetainedEarningsAccumulatedLosses2022-03-3109492560bus:Director12022-04-012023-03-31094925602021-04-012022-03-3109492560core:WithinOneYear2023-03-3109492560core:WithinOneYear2022-03-3109492560core:Non-currentFinancialInstruments2023-03-3109492560core:Non-currentFinancialInstruments2022-03-3109492560bus:PrivateLimitedCompanyLtd2022-04-012023-03-3109492560bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3109492560bus:FRS1022022-04-012023-03-3109492560bus:AuditExemptWithAccountantsReport2022-04-012023-03-3109492560bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP